EcoDrugPlus

Ensembl ID : ENSHHUG00000007245
Gene Symbol: -
Cross references: -
158 Possible Orthologues:

Ensembl ID : ENSHHUG00000019069
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Ensembl ID : ENSHHUG00000029632
Gene Symbol: -
Cross references: -
229 Possible Orthologues:

Ensembl ID : ENSHHUG00000019090
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSHHUG00000018897
Gene Symbol: -
Cross references: -
198 Possible Orthologues:

Ensembl ID : ENSHHUG00000007169
Gene Symbol: -
Cross references: -
200 Possible Orthologues:

Ensembl ID : ENSHHUG00000028789
Gene Symbol: -
Cross references: -
223 Possible Orthologues:

Ensembl ID : ENSHHUG00000028787
Gene Symbol: -
Cross references: -
223 Possible Orthologues:

Ensembl ID : ENSHHUG00000007135
Gene Symbol: -
Cross references: -
189 Possible Orthologues:

Ensembl ID : ENSHHUG00000027513
Gene Symbol: -
Cross references: -
226 Possible Orthologues:

Ensembl ID : ENSHHUG00000019521
Gene Symbol: -
Cross references: -
210 Possible Orthologues:

Ensembl ID : ENSHHUG00000019592
Gene Symbol: -
Cross references: -
194 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).